home / stock / allk / allk short
Short Information | Allakos Inc. (NASDAQ:ALLK)
Twenty Trading Day Totals | |
---|---|
Total Shorted Volume | 2,121,439 |
Total Actual Volume | 18,249,414 |
Short Trends | |
---|---|
Cover Days | 18 |
Short Days | 0 |
No Change Days | 2 |
Averages | |
---|---|
Average Short Volume | 106,072 |
Average Short Percentage | 17.47% |
Is there a ALLK Short Squeeze or Breakout about to happen?
See the ALLK Short Analysis for free Sign up or Login
Powered by Squeeze Report
Date | Open | Close | High | Low | Total Volume | Short Volume | Short Percentage |
---|---|---|---|---|---|---|---|
07-26-2024 | $0.8797 | $0.9151 | $0.9151 | $0.8699 | 207,648 | 12,388 | 5.97% |
07-25-2024 | $0.87 | $0.865 | $0.9466 | $0.8545 | 596,912 | 61,831 | 10.36% |
07-24-2024 | $0.84 | $0.8797 | $0.8797 | $0.8251 | 564,926 | 247,494 | 43.81% |
07-23-2024 | $0.76 | $0.85 | $0.87 | $0.76 | 913,959 | 160,130 | 17.52% |
07-22-2024 | $0.69 | $0.7539 | $0.7545 | $0.675 | 335,480 | 57,092 | 17.02% |
07-19-2024 | $0.75 | $0.6892 | $0.7954 | $0.6856 | 351,133 | 68,667 | 19.56% |
07-18-2024 | $0.81 | $0.75 | $0.8234 | $0.75 | 269,726 | 69,238 | 25.67% |
07-17-2024 | $0.8411 | $0.8235 | $0.875 | $0.804 | 280,262 | 28,757 | 10.26% |
07-16-2024 | $0.87 | $0.8395 | $0.8903 | $0.831 | 415,336 | 40,118 | 9.66% |
07-15-2024 | $0.9 | $0.863 | $0.9071 | $0.851 | 510,668 | 72,790 | 14.25% |
07-12-2024 | $0.8816 | $0.8603 | $0.8899 | $0.8308 | 260,298 | 71,547 | 27.49% |
07-11-2024 | $0.831 | $0.8818 | $0.8897 | $0.831 | 640,415 | 34,310 | 5.36% |
07-10-2024 | $0.82 | $0.83 | $0.84 | $0.817 | 173,888 | 18,093 | 10.4% |
07-09-2024 | $0.796 | $0.8163 | $0.83 | $0.77 | 265,702 | 52,427 | 19.73% |
07-08-2024 | $0.74 | $0.7666 | $0.796 | $0.73 | 454,359 | 90,031 | 19.81% |
07-05-2024 | $0.765 | $0.7323 | $0.77765 | $0.72 | 681,709 | 120,336 | 17.65% |
07-03-2024 | $0.8624 | $0.76 | $0.8799 | $0.76 | 502,389 | 64,056 | 12.75% |
07-02-2024 | $0.89 | $0.8406 | $0.932 | $0.8334 | 758,632 | 287,557 | 37.9% |
07-01-2024 | $1.01 | $0.8798 | $1.03 | $0.8766 | 1,511,852 | 321,994 | 21.3% |
06-28-2024 | $1.06 | $1 | $1.06 | $0.934801 | 8,554,120 | 242,583 | 2.84% |
News, Short Squeeze, Breakout and More Instantly...
– AK006 achieved serum concentrations consistent with levels demonstrating inhibitory activity in preclinical experiments – – Skin biopsies from subjects treated with AK006 show high receptor occupancy – – AK006 was well-tolerated with a favorable safety pro...
– Top-line Phase 1 CSU results expected at year end 2024 – SAN CARLOS, Calif., May 28, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (Nasdaq: ALLK), a biotechnology company developing AK006 for the treatment of mast cell-driven diseases, today announced that the first patient with chr...
SAN CARLOS, Calif., May 09, 2024 (GLOBE NEWSWIRE) -- Allakos Inc. (the “Company”) (Nasdaq: ALLK), a biotechnology company developing antibodies for the treatment of allergic, inflammatory and proliferative diseases, today provided a business update and reported financial results for...